Do you consider your company more of an established pharmaceutical manufacturer?
Visit our section for Pharma Manufacturers
Solving Cold Chain Issues
for Emerging Biopharma
Helping emerging biopharmaceutical companies navigate global regulatory guidelines and tackle cold chain challenges.
LET'S TALK
Cold Chain Challenges for Emerging Biopharma
Whether you develop CAR-T cell therapies, biologics, or other advanced therapies, you’re focused on innovating to bring new clinical trial candidates to market and address unmet medical needs. Companies like yours represent a growing share of the innovation landscape. And with one or more clinical trial candidates in the pipeline, you need to optimize your return on investment. As you build out your in-house staffing, facilities, andcapabilities, a strong network of experienced consultants and contractors can help you reach your goals and put your funding to best use.
Global regulatory guidelines for pharmaceutical cold chain therapies are confusing, complex, and difficult to navigate. Even the most innovative emerging biopharmas typically don’t have the in-house engineering resources, regulatory expertise, or pharmaceutical cold chain filing know-how to tackle these challenges alone. And without easy access to our unique transport simulation technology or deep domain expertise available 24/7, it can be tough to meet complicated requirements and get to market fast.
How Modality Solutions Can Help
Modality Solutions combines all the expertise and experience emerging biopharmas need to achieve your goal and ours: the successful, rapid approval of your therapy. Our end-to-end solution spots issues early in your clinical development cycle—avoiding approval delays, reducing costs, and ensuring successful validation for a timely filing.
We’ve navigated the complexities of NDA and BLA filing for many emerging biopharmas,applying our unrivaled regulatory expertise and biopharma supply chain experience to guide you to filing success.
Case Studies
View All Case Studies
Morphosys Case Study:
How Robust Validation Planning and Transport Simulation Aided Accelerated Approval for MONJUVI™
When MorphoSys obtained Fast Track designation for MONJUVI, a monoclonal antibody treatment for lymphoma, establishing a robust pharmaceutical supply chain was key to gaining commercial..
View the case study now
Atara Biotherapeutics Case Study:
Using Robust Cold Chain Validation to Support CAR-T Therapy Filing
Concerned about vial breakage when transporting its CAR-T therapy on pallets, Atara Biotherapeutics sought to improve the frozen logistics process and support the move to a refrigerated formulation in Phase II...
View the case study now
Immunomedics Case Study:
How Transport Simulation Helped This ADC Therapy Achieve Fast Track Approval
TRODELVY™ represented a promising antibody-drug conjugate therapy for triple negative breast cancer, but filing obstacles threatened its commercialization. Immunomedics tapped Modality Solutions to...
View the case study nowWhy Emerging Biopharmas Partner with Us
Learn More About us- Complete, single-source pharmaceutical cold chain engineering, simulation, and testing capabilities
- Expertise in the complexities of regulatory cold chain requirements and expectations
- Guidance through the entire biopharma cold chain validation process—from proof of biological activity in phase II, to ramp up, through filing, submission, and post-approval commitments
- Support for FDA feedback requests and other urgent situations
Our Solutions
for Emerging Biopharma
Modality Solutions provides the solutions proven to help biopharmaceutical innovators address cold chain challenges and obtain fast therapy approval.
Regulatory Filing
Regulatory Filing
We help prepare you for a successful regulatory filing every step of the way—assessing your cold chain, drug stability, packaging, and third-party logistics qualifications; developing a validation master plan; conducting transport simulation testing; and preparing your team for the CTD submission and pre-approval inspection.
Learn MoreTransport Simulation
Transport Simulation
Whether you need turnkey support or you want to augment your in-house resources, our customizable Transport Simulation Solutions can deliver the robust data regulators expect during your drug’s review and approval. We assess transport risks, develop validation master plans, and rigorously test drug formulations and packaging for the five hazards that can occur in transport—concurrently and at the edges of the supply chain’s operating space—through our ISO-certified Advantage Transport Simulation Laboratory™.
Learn MoreCold Chain Consulting
Cold Chain Consulting
When you’re preparing for a new filing, responding to an Information Request, or looking to improve the supply chain for a commercial product, our Cold Chain Consulting and Cold Chain Engineering™ services are invaluable. Our cold chain consultants and experts draw on their extensive experience to help you overcome complex supply chain challenges, reduce risk, and meet regulatory requirements at every phase.
Learn MoreASTM/ISTA Testing
ASTM/ISTA Testing
Modality Solutions can conduct rigorous, comprehensive testing of your therapeutic against a wide range of ASTM and ISTA standards at our independent Advantage Transport Simulation Laboratory™ or a third-party lab—ranging from plunger movement studies to confirm sterility and efficacy, to drug-device functionality testing, and many other applications.
Learn MoreCold Chain Optimization
Cold Chain Optimization
We help enhance your cold chain’s performance for therapeutics that have already reached the commercial market—reducing shipping and packaging costs while ensuring your drug product remains protected in transit. From package design engineering and evaluation, to packaging selection support, to logistics network design, our Cold Chain Optimization Solutions ensure your supply chain is up to the challenge of transporting fragile or controlled-temperature therapies.
Learn MoreDid You Know?
Emerging Biopharmas drove:
29
Original patents for 29 of the current top 100 drugs, accounting for 40% of US pharmaceutical sales in 2018
65 %
65% of all clinical trials conducted in 2018
58 %
58% of completed clinical trials (among those with a pharma sponsor)
90 %
90+% of next generation biotherapies, including cell and gene therapies and RNAi technologies
Unique Capabilities We Can Put to Work For You
Cold Chain Engineering
Learn More
Transport Simulation Lab
Learn More
AI-Driven Cold Chain Optimization
Learn More
Emergency Response to Regulatory Inquiries
Learn MoreWhat Our Clients Say
“We are very delighted to inform you the FDA has approved tafasitamab. On behalf of the whole team, we want to thank you for your great support. Well done! “
Ready to discuss cold chain needs
for your new biopharmaceutical?
Let's Start a Conversation 
Related Insights
View All ResourcesIs Your Cold Chain Keeping You Up At Night?
In the highly regulated and complex world of biopharmaceutical drug products, ensuring the integrity...
read DetailsBiologic
From Development to Delivery: Comprehensive Project Management for Functional VPs
In the highly regulated and complex world of biopharmaceutical drug products, ensuring the integrity...
read DetailsBiologic
Reliable Partnerships and Regulatory Assurance: The Backbone of Biopharma Logistics
In the highly regulated and complex world of biopharmaceutical drug products, ensuring the integrity...
read DetailsBiologic
